HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wei Wei Prior Selected Research

Class I Phosphatidylinositol 3-Kinases

11/2011Discovery of a potent, selective, and orally available class I phosphatidylinositol 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) kinase inhibitor (GDC-0980) for the treatment of cancer.
7/2010Predictive biomarkers of sensitivity to the phosphatidylinositol 3' kinase inhibitor GDC-0941 in breast cancer preclinical models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wei Wei Prior Research Topics

Disease

11Neoplasms (Cancer)
02/2016 - 02/2010
4Breast Neoplasms (Breast Cancer)
09/2012 - 07/2010
1Lung Neoplasms (Lung Cancer)
12/2011
1Melanoma (Melanoma, Malignant)
12/2011
1Pancreatic Neoplasms (Pancreatic Cancer)
12/2011
1Ovarian Neoplasms (Ovarian Cancer)
09/2010
1Carcinoma (Carcinomatosis)
02/2010

Drug/Important Bio-Agent (IBA)

4Phosphatidylinositols (Phosphatidylinositol)IBA
02/2016 - 02/2010
4Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
09/2012 - 07/2010
42- (1H- indazol- 4- yl)- 6- (4- methanesulfonylpiperazin- 1- ylmethyl)- 4- morpholin- 4- ylthieno(3,2- d)pyrimidineIBA
07/2012 - 07/2010
4Biomarkers (Surrogate Marker)IBA
12/2011 - 02/2010
3Pharmaceutical PreparationsIBA
06/2013 - 09/2010
3TOR Serine-Threonine KinasesIBA
09/2012 - 11/2011
3Phosphotransferases (Kinase)IBA
07/2012 - 11/2011
2Protein Isoforms (Isoforms)IBA
02/2016 - 02/2010
21- (4- ((2- (2- aminopyrimidin- 5- yl)- 7- methyl- 4- morpholinothieno(3,2- d)pyrimidin- 6- yl)methyl)piperazin- 1- yl)- 2- hydroxypropan- 1- oneIBA
09/2012 - 12/2011
2MTOR InhibitorsIBA
12/2011 - 02/2010
2Class I Phosphatidylinositol 3-KinasesIBA
11/2011 - 07/2010
12- (3- (2- (1- isopropyl- 3- methyl- 1H- 1,2- 4- triazol- 5- yl)- 5,6- dihydrobenzo(f)imidazo(1,2- d)(1,4)oxazepin- 9- yl)- 1H- pyrazol- 1- yl)- 2- methylpropanamideIBA
06/2013
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
09/2012
1Proteins (Proteins, Gene)FDA Link
09/2012
1Phenobarbital (Luminal)FDA Link
07/2012
1Docetaxel (Taxotere)FDA Link
07/2012
1LipidsIBA
07/2012
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
12/2011
1TensinsIBA
12/2011
1Doxorubicin (Adriamycin)FDA LinkGeneric
09/2010
1DNA (Deoxyribonucleic Acid)IBA
09/2010
1Tumor Biomarkers (Tumor Markers)IBA
09/2010
1Proline (L-Proline)FDA Link
09/2010
1Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA
02/2010

Therapy/Procedure

2Therapeutics
02/2016 - 09/2010